Paul MacLeman has over 25 years’ experience across all phases of the life sciences sector. With a career-spanning veterinary practice, pharmaceutical development and manufacturing, biotechnology, diagnostics and finance, Paul has expertise in capital raising, business development, technology commercialisation, and sales and marketing globally. Paul has launched products using both in-house and outsourced sales staff in Australia and the US. He has founded life sciences start-ups in the biologics area and worked in investment banking, focusing on the analysis and financing of technology companies. Paul has previously served as Chairman, Director or Managing Director/CEO of several VC funded ASX, NASDAQ, CSE and TSX listed companies. Paul is currently Executive Chairman of Isla Pharmaceuticals Inc. and Chairman of AdAlta Limited (1AD:ASX).
Paul is currently Executive Chairman of Isla Pharmaceuticals Inc. and Chairman of AdAlta Limited (1AD:ASX). Paul chairs the Industry Review Committee for the Pharmaceutical Manufacturing National Training Package for the AISC. He is an expert advisor to PharmaVentures (Oxford, UK) and Mind Medicine. Paul also serves on a number of other not-for-profit and government advisory groups and has recently provided advice to both the Department of Education, Skills and Employment (DESE) and the Department of Industry, Science, Energy and Resources (DISER) related to COVID-19.